Scarica l'app Stockscreener
1.08
0.92%
-0.01
Dopo l'orario di chiusura:
1.12
0.04
+3.70%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.09
Aprire:
$1.1
Volume 24 ore:
194.10K
Relative Volume:
0.48
Capitalizzazione di mercato:
$20.04M
Reddito:
-
Utile/perdita netta:
$-25.56M
Rapporto P/E:
-0.2077
EPS:
-5.2
Flusso di cassa netto:
$-19.35M
1 W Prestazione:
+3.85%
1M Prestazione:
-6.90%
6M Prestazione:
-64.00%
1 anno Prestazione:
-77.16%
Intervallo 1D:
$1.075
$1.12
Intervallo di 1 settimana:
$1.0103
$1.13
Portata 52W:
$0.62
$7.50
Biovie Inc Stock (BIVI) Company Profile
Nome
Biovie Inc
Settore
Industria
Telefono
775-888-3162
Indirizzo
680 W NYE LANE, CARSON CITY
Confronta BIVI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.08 | 19.68M | 0 | -25.56M | -19.35M | -5.20 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.232 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.34 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Iniziato | B. Riley Securities | Buy |
Biovie Inc Borsa (BIVI) Ultime notizie
New to The Street Announces Upcoming Bloomberg Air Dates Featuring FLOKI, BioVie Pharmaceuticals, Beeline, Arrive AI, and Commercialville - ACCESS Newswire
Northern Trust Corp Buys Shares of 16,878 BioVie Inc. (NASDAQ:BIVI) - Defense World
SHAREHOLDER ALERT: Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire
The Law Offices of Vincent Wong Remind BioVie Investors of a Lead Plaintiff Deadline of March 19, 2024 - marketscreener.com
BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lohud
Investors' Lawsuit Against BioVie Moves to Evidence Review — Here's How to Recover Losses - TradingView
Transcript : BioVie Inc.Special Call - marketscreener.com
BioVie (NASDAQ:BIVI) Trading 1.9% Higher – Time to Buy? - Defense World
FY2025 EPS Estimates for BioVie Raised by Analyst - Defense World
BioVie Inc. Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID - marketscreener.com
BioVie (BIVI) Begins Phase 2 Trial for Long COVID Treatment | BI - GuruFocus
BioVie (BIVI) Begins Phase 2 Trial for Long COVID Treatment | BIVI Stock News - GuruFocus
BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial - GlobeNewswire
New Long COVID Treatment Hope: BioVie Launches Phase 2 Trial for 20M+ US Patients with Brain Fog - Stock Titan
BioVie (BIVI) To Host Key Opinion Leader Event Discussing Parkin - GuruFocus
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of - GuruFocus
BioVie to host KOL event on Phase 2 study of bezisterim - TipRanks
BioVie Inc. to Host Virtual KOL Event Discussing Parkinson’s Disease and Update on Phase 2 SUNRISE-PD Trial for Bezisterim - Nasdaq
BioVie to Host Virtual KOL Event to Discuss the Phase 2 - GlobeNewswire
Biovie Inc. to Host Virtual Kol Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025 - marketscreener.com
Critical Survey: Coya Therapeutics (NASDAQ:COYA) vs. BioVie (NASDAQ:BIVI) - Defense World
BIOVIE Earnings Results: $BIVI Reports Quarterly Earnings - Nasdaq
BIOVIE INC. SEC 10-Q Report - TradingView
Lost Money on BioVie Inc.(BIVI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire
BioVie (BIVI) to Release Quarterly Earnings on Tuesday - Defense World
Investors who lost money on BioVie Inc. (BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire
BioVie Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 19, 2024 to Discuss Your RightsBIVI - ACCESS Newswire
Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire
Investors who lost money on BioVie Inc.(BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire
Levi & Korsinsky Reminds BioVie Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024BIVI - ACCESS Newswire
Shareholders that lost money on BioVie Inc.(BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
INVESTOR ALERT: Potential Recovery for BioVie Inc. (BIVI) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Shareholders that lost money on BioVie Inc. (BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Shareholders that lost money on BioVie Inc. (BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Investors to Reach Out - ACCESS Newswire
BioVie to Present Rationale and Design of Phase 2 - GlobeNewswire
BioVie (BIVI) Showcases Parkinson's Trial at Global Conference | BIVI Stock News - GuruFocus
Market Insights: BioVie Inc (BIVI)’s Notable Gain of 1.75, Closing at 1.16 - DWinneX
BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congress on Parkinson’s Disease and Related Disorders (IAPRD 2025) - TradingView
BioVie (BIVI) Establishes Influential Corporate Advisory Board | - GuruFocus
BioVie assembles advisory board for neurodegenerative care By Investing.com - Investing.com Canada
BioVie (BIVI) Establishes Influential Corporate Advisory Board | BIVI Stock News - GuruFocus
BioVie assembles advisory board for neurodegenerative care - Investing.com
BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth - The Manila Times
BioVie (BIVI) Advances Parkinson's Trial with Innovative Drug Be - GuruFocus
BioVie (BIVI) Advances Key Drug Treatments and Clinical Trials - GuruFocus
BioVie Unveils Corporate Advisory Board Featuring Neuralink - GlobeNewswire
BioVie Inc. Announces Formation of Corporate Advisory Board - marketscreener.com
BioVie (BIVI) Advances Parkinson's Trial with Innovative Drug Bezisterim - GuruFocus
Geode Capital Management LLC Buys 85,234 Shares of BioVie Inc. (NASDAQ:BIVI) - Defense World
INVESTOR ALERT: Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire
Biovie Inc Azioni (BIVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
2.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):